Axios Pro Exclusive Content
Colossal Biosciences raises $150M to revive the dodo

- Alan Neuhauser, author ofAxios Pro: Climate Deals
Jan 31, 2023

Illustration: Tiffany Herring/Axios
Colossal Biosciences, the Austin-based "de-extinction" company that's bringing back the woolly mammoth and Tasmanian tiger, closed a $150 million Series B to fund a new effort to revive the dodo.
Why it matters: The climate movement, at its most fundamental level, is about protecting the Earth. Colossal Biosciences hopes to repair some of the damage already done.
Axios Pro
Unlock this article for free
Already a subscriber?
Axios may use your email in accordance with our Privacy Policy including for marketing purposes and promotional emails.